<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04941248</url>
  </required_header>
  <id_info>
    <org_study_id>KY2021-086</org_study_id>
    <nct_id>NCT04941248</nct_id>
  </id_info>
  <brief_title>Total-body 13N-NH3 PET/CT to Study the Blood Perfusion in Whole Body</brief_title>
  <official_title>The Application of Total-body 13N-NH3 PET/CT to Study the Blood Perfusion System in the Whole Body</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RenJi Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>RenJi Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of our study is to analyze and quantitate whole-body blood perfusion by total-body&#xD;
      13N-NH3 PET/CT(uEXPLORER), and evaluate the influence to other organs caused by the decreased&#xD;
      EF value or aortic stenosis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants are invited to participate in a research that seeks to understand the dynamic&#xD;
      blood perfusion in human body. The investigators expect to have sixteen participants in this&#xD;
      study at Renji Hospital, Shanghai. About four of the participants will be patients who have&#xD;
      been diagnosed with decreased ejection fraction(EF) value, three participants will be healthy&#xD;
      individuals with no known vascular disease, and about 9 patients will be patients with aortic&#xD;
      stenosis. These healthy subjects will allow researchers to compare blood perfusion difference&#xD;
      with those of persons with decreased EF value or aortic stenosis. All the participants will&#xD;
      undergo the same procedure.&#xD;
&#xD;
      If participants agree to participate in this study, researchers will first interview&#xD;
      participants and review the past medical record in order to document the medical history.&#xD;
      When the screening procedures confirm that participants are eligible to participate in the&#xD;
      study, participants will receive one dose of the non-therapeutic administration of a&#xD;
      radioactive tracer called N-13 ammonia(13NH3) , then undergo one total body 13NH3 PET/CT Scan&#xD;
      (uEXPLORER) to determine the blood flow value of the brain, kidney and other organs. The&#xD;
      total body 13NH3 PET/CT Scan will allow investigators to observe and analyze the real-time&#xD;
      blood flow differences between patients with between healthy controls and decreased EF value&#xD;
      or aortic stenosis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 27, 2021</start_date>
  <completion_date type="Anticipated">January 8, 2023</completion_date>
  <primary_completion_date type="Anticipated">November 8, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of Multi-Organ Blood Perfusion by Total Body Dynamic uEXPLORER PET/CT Scan</measure>
    <time_frame>2 years</time_frame>
    <description>The total-body 13N-NH3 PET/CT will be adopted to evaluate the blood flow differences in whole body between healthy controls and patients with decreased EF value or aortic stenosis.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">16</enrollment>
  <condition>Cardiac Output</condition>
  <arm_group>
    <arm_group_label>Healthy controls</arm_group_label>
    <description>All healthy subjects will undergo the following intervention: 13N-NH3 PET/CT scan on the total-body uEXPLORER scanner.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with decreased EF value or aortic stenosis</arm_group_label>
    <description>All patients will undergo the following intervention: 13N-NH3 PET/CT scan on the total-body uEXPLORER scanner.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>total-body PET/CT(uEXPLORER , United Imaging Healthcare, China)</intervention_name>
    <description>This prospective study will enroll sixteen patients, including three healthy volunteers, four patients with moderate or mild decreased EF values, and nine patients with aortic stenosis . All of them will have a whole-body PET/CT(uEXPLORER , United Imaging Healthcare, China) in our department, Renji Hospital.</description>
    <arm_group_label>Healthy controls</arm_group_label>
    <arm_group_label>Patients with decreased EF value or aortic stenosis</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Individuals aged between 18 and 75 years old Patients with diagnosis of moderate/mild&#xD;
        decreased EF values or aortic stenosis will be eligible for our enrollment; and&#xD;
        participants without any history of vascular disease will be eligible.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Three healthy volunteers with normal EF values&#xD;
&#xD;
          -  Four patients with moderate or mild decreased EF values, while their heart function&#xD;
             grading above II(New York Heart Association,NYHA)&#xD;
&#xD;
          -  Nine patients with aortic stenosis&#xD;
&#xD;
          -  Aged 18~75 years old&#xD;
&#xD;
          -  Written informed consents will be offered and signed by all participants&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of vascular-related diseases in other organs&#xD;
&#xD;
          -  Severe liver and kidney dysfunctions&#xD;
&#xD;
          -  Patients who are pregnant or breast feeding&#xD;
&#xD;
          -  People under the age of 18 years old&#xD;
&#xD;
          -  Heart function grading below II(NYHA)&#xD;
&#xD;
          -  inability to lie or to maintain posture in the scanner for one hour&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yumei Chen, Ph.D; M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shanghai jiaotong University School of Medicine, Renji Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yumei Chen, Ph.D; M.D.</last_name>
    <phone>86-021-58752345</phone>
    <email>chym0215@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Xiaofeng Yu</last_name>
    <phone>86-021-58752345</phone>
    <email>minkeyperfect@126.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Shanghai jiaotong University School of Medicine, Renji Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200127</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yumei Chen, Ph.D;M.D.</last_name>
      <phone>86-021-58752345</phone>
      <email>chym0215@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Benz DC, Ferro P, Safa N, Messerli M, von Felten E, Huang W, Patriki D, Giannopoulos AA, Fuchs TA, Gräni C, Gebhard C, Pazhenkottil AP, Kaufmann PA, Buechel RR. Role of quantitative myocardial blood flow and (13)N-ammonia washout for viability assessment in ischemic cardiomyopathy. J Nucl Cardiol. 2021 Feb;28(1):263-273. doi: 10.1007/s12350-019-01684-1. Epub 2019 Mar 20.</citation>
    <PMID>30895563</PMID>
  </reference>
  <reference>
    <citation>Lang JK, Canty JM Jr. The complexity of using resting myocardial perfusion to assess myocardial viability and predict functional recovery. J Nucl Cardiol. 2021 Feb;28(1):274-277. doi: 10.1007/s12350-019-01742-8. Epub 2019 May 13.</citation>
    <PMID>31087267</PMID>
  </reference>
  <reference>
    <citation>Kang KW, Kim JS, Cho SG, Kim J, Song HC. Acquisition of dynamic N-13 ammonia PET for myocardial blood flow quantification. J Nucl Cardiol. 2020 Aug;27(4):1288-1292. doi: 10.1007/s12350-020-02062-y. Epub 2020 Feb 19.</citation>
    <PMID>32076961</PMID>
  </reference>
  <reference>
    <citation>Giubbini R, Peli A, Milan E, Sciagrà R, Camoni L, Albano D, Bertoli M, Bonacina M, Motta F, Statuto M, Rodella CA, De Agostini A, Calabretta R, Bertagna F; Italian Nuclear Cardiology Group (GICN). Comparison between the summed difference score and myocardial blood flow measured by (13)N-ammonia. J Nucl Cardiol. 2018 Oct;25(5):1621-1628. doi: 10.1007/s12350-017-0789-z. Epub 2017 Feb 3.</citation>
    <PMID>28160262</PMID>
  </reference>
  <reference>
    <citation>Sciagrà R, Lubberink M, Hyafil F, Saraste A, Slart RHJA, Agostini D, Nappi C, Georgoulias P, Bucerius J, Rischpler C, Verberne HJ; Cardiovascular Committee of the European Association of Nuclear Medicine (EANM). EANM procedural guidelines for PET/CT quantitative myocardial perfusion imaging. Eur J Nucl Med Mol Imaging. 2021 Apr;48(4):1040-1069. doi: 10.1007/s00259-020-05046-9. Epub 2020 Nov 2.</citation>
    <PMID>33135093</PMID>
  </reference>
  <reference>
    <citation>Lammertsma AA. Forward to the Past: The Case for Quantitative PET Imaging. J Nucl Med. 2017 Jul;58(7):1019-1024. doi: 10.2967/jnumed.116.188029. Epub 2017 May 18. Review.</citation>
    <PMID>28522743</PMID>
  </reference>
  <reference>
    <citation>Akamatsu G, Uba K, Taniguchi T, Mitsumoto K, Narisue A, Tsutsui Y, Sasaki M. Impact of Time-of-Flight PET/CT with a Large Axial Field of View for Reducing Whole-Body Acquisition Time. J Nucl Med Technol. 2014 Jun;42(2):101-4. doi: 10.2967/jnmt.114.140665. Epub 2014 May 5.</citation>
    <PMID>24799607</PMID>
  </reference>
  <reference>
    <citation>Zhang X, Cherry SR, Xie Z, Shi H, Badawi RD, Qi J. Subsecond total-body imaging using ultrasensitive positron emission tomography. Proc Natl Acad Sci U S A. 2020 Feb 4;117(5):2265-2267. doi: 10.1073/pnas.1917379117. Epub 2020 Jan 21.</citation>
    <PMID>31964808</PMID>
  </reference>
  <reference>
    <citation>Zhang X, Xie Z, Berg E, Judenhofer MS, Liu W, Xu T, Ding Y, Lv Y, Dong Y, Deng Z, Tang S, Shi H, Hu P, Chen S, Bao J, Li H, Zhou J, Wang G, Cherry SR, Badawi RD, Qi J. Total-Body Dynamic Reconstruction and Parametric Imaging on the uEXPLORER. J Nucl Med. 2020 Feb;61(2):285-291. doi: 10.2967/jnumed.119.230565. Epub 2019 Jul 13.</citation>
    <PMID>31302637</PMID>
  </reference>
  <reference>
    <citation>Cherry SR, Jones T, Karp JS, Qi J, Moses WW, Badawi RD. Total-Body PET: Maximizing Sensitivity to Create New Opportunities for Clinical Research and Patient Care. J Nucl Med. 2018 Jan;59(1):3-12. doi: 10.2967/jnumed.116.184028. Epub 2017 Sep 21. Review.</citation>
    <PMID>28935835</PMID>
  </reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>June 15, 2021</study_first_submitted>
  <study_first_submitted_qc>June 20, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 28, 2021</study_first_posted>
  <last_update_submitted>September 24, 2021</last_update_submitted>
  <last_update_submitted_qc>September 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>RenJi Hospital</investigator_affiliation>
    <investigator_full_name>Yumei Chen</investigator_full_name>
    <investigator_title>deputy head of the department of nuclear medicine</investigator_title>
  </responsible_party>
  <keyword>Total-body; PET/CT; N-13 ammonia; Blood perfusion</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

